The utility of SELENBP1 gene expression as a biomarker for major psychotic disorders: replication in schizophrenia and extension to bipolar disorder with psychosis
While microarray studies are generating novel insights into the etiology of major psychiatric
disorders, the validation of microarray‐identified candidate genes and their role in the …
disorders, the validation of microarray‐identified candidate genes and their role in the …
[引用][C] The Utility of SELENBP1 Gene Expression as a Biomarker for Major Psychotic Disorders: Replication in Schizophrenia and Extension to Bipolar Disorder With …
T KANAZAWA, G CHANA, SJ GLATT… - American journal of …, 2008 - pascal-francis.inist.fr
The Utility of SELENBP1 Gene Expression as a Biomarker for Major Psychotic Disorders :
Replication in Schizophrenia and Extension to Bipolar Disorder With Psychosis CNRS Inist …
Replication in Schizophrenia and Extension to Bipolar Disorder With Psychosis CNRS Inist …
The utility of SELENBP1 gene expression as a biomarker for major psychotic disorders: replication in schizophrenia and extension to bipolar disorder with psychosis.
T Kanazawa, G Chana, SJ Glatt, H Mizuno… - American Journal of …, 2008 - europepmc.org
While microarray studies are generating novel insights into the etiology of major psychiatric
disorders, the validation of microarray-identified candidate genes and their role in the …
disorders, the validation of microarray-identified candidate genes and their role in the …
The utility of SELENBP1 gene expression as a biomarker for major psychotic disorders: replication in schizophrenia and extension to bipolar disorder with psychosis
T Kanazawa, G Chana, SJ Glatt… - … journal of medical …, 2008 - pubmed.ncbi.nlm.nih.gov
While microarray studies are generating novel insights into the etiology of major psychiatric
disorders, the validation of microarray-identified candidate genes and their role in the …
disorders, the validation of microarray-identified candidate genes and their role in the …